Janus Henderson Group

Janus Henderson Group’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Janus Henderson Group’s Portfolio CYT Stock Details CYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,719,610	Closed	-$6.49M	–	2716
2022 Q1	$6.49M	Sell	1,719,610 -152,811	-8%	-$870K	﹤0.01%	962
2021 Q4	$20.6M	Sell	1,872,421 -5,803	-0.3%	-$88.4K	0.01%	779
2021 Q3	$31.9M	Sell	1,878,224 -11,609	-0.6%	-$217K	0.01%	675
2021 Q2	$37.9M	Buy	+1,889,833	New	+$35.4M	0.02%	639

Other funds holding CYT

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return